[The formulation of the current management of patients with atypical hyperplasia (AH)].
The authors study is the receptor status of 16 patients with AH. The amount of ER and PR in patients with AH is compared to the amount of the same receptors in patients with highly differentiated adenocarcinoma. A progestin treatment is proposed for AH together with dynamic evaluation of the amount of ER and PR. In patients ER, PR, even if they have not complete their reproduction, hysterectomy is proposed. The cases ER+, PR+ are actively followed up. Every patients should undergo complex investigation and evaluation in which together with the receptor status extremely important is the routine biopsy.
Gorchev
G
G
Milkov
V
V
Popov
I
I
Rachev
E
E
D001706:Biopsy; D004714:Endometrial Hyperplasia / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D004717:Endometrium / Q000737:chemistry / Q000473:pathology; D005260:Female; D006801:Humans; D007044:Hysterectomy; D011869:Radioligand Assay; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
Izgrazhdane na sŭvremenno povedenie pri bolni s atipichna khiperplaziia (AKh).